0001193125-18-269299.txt : 20180907 0001193125-18-269299.hdr.sgml : 20180907 20180907172405 ACCESSION NUMBER: 0001193125-18-269299 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180907 DATE AS OF CHANGE: 20180907 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Reis, Inc. CENTRAL INDEX KEY: 0001038222 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 133926898 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-51221 FILM NUMBER: 181060896 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: FLOOR 30 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 2129211122 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: FLOOR 30 CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: WELLSFORD REAL PROPERTIES INC DATE OF NAME CHANGE: 19970423 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Garfield Jonathan CENTRAL INDEX KEY: 0001400896 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: C/O REIS SERVICES LLC STREET 2: 530 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 SC 13D/A 1 d619863dsc13da.htm SC 13D/A - AMENDMENT NO.8 SC 13D/A - Amendment No.8

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(a)

Under the Securities Exchange Act of 1934

(Amendment No. 8)*

 

 

Reis, Inc.

(Name of Issuer)

Common Stock, par value $0.02 per share

(Title Class of Securities)

75936P 105

(CUSIP Number)

Jonathan Garfield

c/o Reis, Inc.

1185 Avenue of the Americas

New York, NY 10036

(212) 921-1122

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

August 29, 2018

(Date of Event which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ☐

 

 

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

 

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 75936P 105    13D    Page 2 of 5

 

  1   

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

Jonathan Garfield

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)

(a)  ☐        (b)  ☐

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS (see Instructions)

 

OO

  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  ☐

 

  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF 

SHARES 

BENEFICIALLY 

OWNED BY 

EACH

REPORTING 

PERSON

WITH

 

     7       

SOLE VOTING POWER

 

925,264 shares of Common Stock

     8   

SHARED VOTING POWER

 

36,093 shares of Common Stock

     9   

SOLE DISPOSITIVE POWER

 

925,264 shares of Common Stock

   10   

SHARED DISPOSITIVE POWER

 

36,093 shares of Common Stock

11      

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

961,357 shares of Common Stock

12  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)  ☐

 

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

8.1%

14  

TYPE OF REPORTING PERSON (see Instructions)

 

IN


This statement constitutes Amendment No.8 (“Amendment No.8”) to the statement on Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) by Jonathan Garfield (the “Reporting Person”) in connection with the ownership of Common Stock, par value $0.02 per share (the “Common Stock”), of Reis, Inc., a Maryland corporation (the “Company”), with its principal executive offices at 1185 Avenue of the Americas, New York, NY 10036, as such Schedule 13D has previously been amended and supplemented (the “Schedule 13D”).

In accordance with Act Rule 13d-2, this Amendment No.8 amends and supplements only information that has materially changed since the November 12, 2015 filing by the Reporting Person of Amendment No.7 to the Schedule 13D. Unless otherwise stated, the information set forth in the Schedule 13D remains accurate in all material respects. Unless otherwise defined herein, capitalized terms herein shall have the meanings set forth in the Schedule 13D.

 

Item 4.

Purpose of Transaction.

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following:

On August 29, 2018, the Company, Moody’s Corporation, a Delaware corporation (“Moody’s”), and Moody’s Analytics Maryland Corp., a Maryland corporation and wholly-owned subsidiary of Moody’s (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which Merger Sub will commence a tender offer (the “Offer”) to purchase all outstanding shares of Common Stock at a price of $23.00 per share of Common Stock (the “Offer Price”), subject to any required withholding of taxes, net to the selling stockholders in cash without interest. Following completion of the Offer, Merger Sub will be merged with and into the Company, on the terms and subject to the conditions set forth in the Merger Agreement (the “Merger”), with the Merger to be effected pursuant to Section 3-106.1 of the Maryland General Corporation Law, as amended, with the Company surviving the Merger as a wholly owned subsidiary of Moody’s. At the effective time of the Merger, each share of Common Stock not purchased in the Offer (other than the shares of Common Stock held directly or indirectly by any of the Company’s wholly-owned subsidiaries or by Moody’s or any of its subsidiaries (including Merger Sub)) will be converted into the right to receive an amount, in cash and without interest, equal to the Offer Price.

On August 29, 2018, in connection with the execution of the Merger Agreement, the Reporting Person entered into a Tender and Support Agreement with Moody’s and Merger Sub (the “Tender and Support Agreement”), pursuant to which the Reporting Person has agreed to, among other things, tender all of his shares of Common Stock that he beneficially owns in the Offer.

The foregoing summary of the material terms of the Tender and Support Agreement is not complete and is qualified in its entirety by reference to the Tender and Support Agreement, which is filed as Exhibit 99.5 attached hereto and incorporated herein by reference.

 

Item 5.

Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is amended and restated in its entirety as follows:

(a) Based on the 11,810,699 shares of Common Stock of the Company (which includes 241,000 shares of Common Stock reserved for issuance upon the exercise of outstanding vested stock options) outstanding as of August 24, 2018 (as disclosed in the Merger Agreement), the Reporting Person is the beneficial owner of 961,357 shares of Common Stock, including 100,000 shares of Common Stock issuable upon the exercise of vested stock options held by the Reporting Person (collectively, the “Reported Shares”), representing approximately 8.1% of the issued and outstanding Common Stock of the Company. The Reported Shares include 36,093 shares of Common Stock held by the Jonathan Garfield Family Trust (the “Family Trust”) by virtue of the fact that the trustee is the Reporting Person’s wife, Ms. Celia J. Hartmann.

(b) The Reporting Person has the sole power to vote or direct the vote of, and to dispose of or direct the disposition of, all of the Reported Shares except the 36,093 shares of Common Stock held by the Family Trust. The Reporting Person may be deemed to share with his wife, trustee for the Family Trust, voting and dispositive power with respect to the 36,093 Reported Shares held by the Family Trust. Ms. Celia J. Hartmann’s business address is The Metropolitan Museum of Art, 1000 Fifth Avenue, New York, NY 10028, and her principal occupation is Senior Associate for Archival Processing. During the past five years, Ms. Hartmann has not been convicted in any criminal proceeding described in Item 2(d) of Schedule 13D nor has she been a party to any civil proceeding described in Item 2(e) of Schedule 13D. Ms. Hartmann is a citizen of the United States and a resident of New York.

(c) Except as described herein, the Reporting Person has not effected any transactions in the Reported Shares during the past sixty days.

(d) With respect to the 36,093 Reported Shares held by the Family Trust, the Family Trust has the right to receive dividends from, or the proceeds from the sale of, such Reported Shares.

(e) Not applicable.


Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Item 6 of the Schedule 13D is hereby amended and supplemented by adding the following:

The matters set forth in Item 4 above are incorporated into this Item 6 by reference as if fully set forth herein.

 

Item 7.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Item 7 of the Schedule 13D is hereby amended to add the following exhibit:

 

    Exhibit 99.5 -   Tender and Support Agreement, by and among Jonathan Garfield, Jonathan T. Garfield 2016 Qualified Annuity Trust, Jonathan Garfield Family Trust, Moody’s Corporation and Moody’s Analytics Maryland Corp., dated August 29, 2018 (incorporated by reference to Exhibit 99.1 to the Form 8-K filed by Reis, Inc. on August 30, 2018).


Signatures

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and accurate.

 

      /s/ Jonathan Garfield
Dated: September 7, 2018       Jonathan Garfield